Efficiency of nicotinamide-based supportive therapy in lymphopenia for patients with ordinary or severe COVID-19: A randomized controlled trial.
Medicine (Baltimore)
; 101(43): e31138, 2022 Oct 28.
Article
in En
| MEDLINE
| ID: mdl-36316932
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
/
Lymphopenia
Type of study:
Clinical_trials
/
Etiology_studies
Limits:
Humans
Language:
En
Journal:
Medicine (Baltimore)
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
United States